Type A aortic dissection (TAAD) is a potentially life-threatening pathology associated with significant risk of mortality and morbidity. In acute forms of type A aortic dissection (TAAD) mortality is 50% by 24 h and 50% of patients die before reaching a specialist center. Rapid diagnosis and subsequent prompt surgical repair remain the primary goal for these patients. In the last decade it has been observed that improvements in diagnostic techniques, initial management and increased clinical awareness have contributed to a substantial increase in the number of patients benefiting from a prompt diagnosis and undergoing surgery.However, survival after surgical repair has not yet reached optimal follow-ups and is burdened by high in-hospital mortality(16-18%)The main approach to acute type B non-complicated aortic dissection (TBAD) has always been to use medicines to control the patient's heart rate and blood pressure. However, recent findings suggest that a large number of patients treated for acute complicated (TBAAD) and non-complicated TBAD experience aortic complications, such as aneurysmal degeneration, at a later stage.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Operative Mortality (OM)
Timeframe: 30-day
Rate of mesenteric ischemia
Timeframe: 30-day
Rate of permanent Neurologic Deficit (PND)
Timeframe: 30-day
Rate of composite of Major Adverse Events (MAE)
Timeframe: 30-day
Rate of perioperative Myocardial Infarction (MI)
Timeframe: 30-day
Rate of acute heart failure (AHF)
Timeframe: 30-day and in-hospital mortality